• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚原住民的肺活量参考值:系统评价。

Spirometry reference values in Indigenous Australians: a systematic review.

机构信息

Centre for Children's Health Research, Queensland University of Technology, Brisbane, QLD

Respiratory and Sleep Medicine, Lady Cilento Children's Hospital, Brisbane, QLD.

出版信息

Med J Aust. 2016 Jul 4;205(1):35-40. doi: 10.5694/mja16.00226.

DOI:10.5694/mja16.00226
PMID:27362686
Abstract

OBJECTIVES

To evaluate published spirometry data for Australian Aboriginal and Torres Strait Islander (Indigenous) peoples to determine (i) whether their ethnicity influenced spirometry results; and (ii) if any reliable spirometry reference values exist for Indigenous Australians.

STUDY DESIGN

Systematic review of published and grey literature.

DATA SOURCES

PubMed and Cochrane Library databases, references of included articles and appropriate grey literature. Last searches were conducted in April 2016.

STUDY SELECTION

We included any study that performed spirometry on healthy Indigenous Australians and compared their results with those from people of European ancestry. Two authors independently screened titles and abstracts and then reviewed potentially relevant full-text articles for possible inclusion. We used PRISMA systematic review reporting methods to collate data.

DATA SYNTHESIS

Of a possible 125 studies, 18 full-text articles were reviewed, but only nine fulfilled the inclusion criteria. None specified Torres Strait Islander inclusion. All studies reported lower spirometry values (as much as 30% lower) for Aboriginal people compared with non-Indigenous people. Five studies developed spirometry reference values for Indigenous Australians; however, none adhered to all participant inclusion and exclusion criteria outlined by the American Thoracic Society and European Respiratory Society. Hence, reported results and subsequent reference values may not be a true representation of spirometry values in healthy Indigenous people.

CONCLUSIONS

The lower spirometry values reported for Indigenous Australians may be due to study limitations. Furthermore, there are currently no reliable spirometry reference values for Indigenous Australians that adhere to current guidelines. Developing a set of Indigenous Australian reference values will improve the accuracy of test interpretation and aid in the diagnosis of respiratory disease in this population.

摘要

目的

评估已发表的澳大利亚原住民和托雷斯海峡岛民(土著)人群的肺活量测定数据,以确定:(i)他们的种族是否影响肺活量测定结果;以及(ii)是否存在适用于澳大利亚土著人的可靠肺活量测定参考值。

研究设计

已发表和灰色文献的系统评价。

数据来源

PubMed 和 Cochrane 图书馆数据库、纳入文章的参考文献和适当的灰色文献。最后一次搜索是在 2016 年 4 月进行的。

研究选择

我们纳入了对健康澳大利亚土著人进行肺活量测定并将其结果与欧洲血统人群进行比较的任何研究。两位作者独立筛选标题和摘要,然后审查潜在相关的全文文章以确定是否纳入。我们使用 PRISMA 系统评价报告方法来整理数据。

综合结果

在可能的 125 项研究中,有 18 篇全文文章进行了审查,但只有 9 篇符合纳入标准。没有研究明确包括托雷斯海峡岛民。所有研究都报告说,与非土著人相比,原住民的肺活量测定值较低(低达 30%)。五项研究为澳大利亚土著人制定了肺活量测定参考值;然而,没有一项研究符合美国胸科学会和欧洲呼吸学会规定的所有参与者纳入和排除标准。因此,报告的结果和随后的参考值可能无法真实反映健康土著人的肺活量测定值。

结论

报告的澳大利亚原住民肺活量较低可能是由于研究限制所致。此外,目前没有适用于澳大利亚土著人的可靠肺活量测定参考值,这些参考值符合现行指南。制定一套澳大利亚土著人的参考值将提高测试解释的准确性,并有助于在该人群中诊断呼吸疾病。

相似文献

1
Spirometry reference values in Indigenous Australians: a systematic review.澳大利亚原住民的肺活量参考值:系统评价。
Med J Aust. 2016 Jul 4;205(1):35-40. doi: 10.5694/mja16.00226.
2
Defining the gap: a systematic review of the difference in rates of diabetes-related foot complications in Aboriginal and Torres Strait Islander Australians and non-Indigenous Australians.界定差距:对澳大利亚原住民和托雷斯海峡岛民与非原住民澳大利亚人糖尿病相关足部并发症发生率差异的系统评价。
J Foot Ankle Res. 2017 Nov 7;10:48. doi: 10.1186/s13047-017-0230-5. eCollection 2017.
3
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Effects of a culturally informed model of care for Aboriginal and Torres Strait Islander patients with acute coronary syndrome in a tertiary hospital in Australia: a pre-post, quasi-experimental, interventional study.澳大利亚一家三级医院中针对患有急性冠状动脉综合征的原住民和托雷斯海峡岛民患者的文化适应性护理模式的效果:一项前后对照、准实验性干预研究。
Lancet Glob Health. 2024 Apr;12(4):e623-e630. doi: 10.1016/S2214-109X(23)00601-0.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Scanning the respiratory service landscape in NSW-based Aboriginal Community Controlled Health Services.审视新南威尔士州原住民社区控制卫生服务机构中的呼吸科服务情况。
BMC Health Serv Res. 2025 Aug 27;25(1):1135. doi: 10.1186/s12913-025-13361-w.
2
The 'ABC' of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians - a systematic review.成人原住民呼吸障碍的“ABC”:澳大利亚原住民的哮喘、支气管扩张症和 COPD - 系统评价。
BMJ Open Respir Res. 2023 Jul;10(1). doi: 10.1136/bmjresp-2023-001738.
3
Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.
探索澳大利亚北部顶端地区的澳大利亚原住民使用吸入性药物治疗的处方实践是否合适:一项回顾性队列研究。
BMJ Open Respir Res. 2023 Mar;10(1). doi: 10.1136/bmjresp-2022-001508.
4
Differences in the Spirometry Parameters Between Indigenous and Non-Indigenous Patients with COPD: A Matched Control Study.慢性阻塞性肺疾病(COPD)患者的肺功能参数在土著和非土著患者之间的差异:一项匹配对照研究。
Int J Chron Obstruct Pulmon Dis. 2022 Apr 21;17:869-881. doi: 10.2147/COPD.S361839. eCollection 2022.
5
Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease.澳大利亚原住民慢性气道疾病患者与非患者的肺功能参数的性别差异。
PLoS One. 2022 Feb 8;17(2):e0263744. doi: 10.1371/journal.pone.0263744. eCollection 2022.
6
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.使用 GLI-2012、GOLD 和澳大利亚 COPD-X 建议评估 COPD 土著人群中肺功能气流受限严重程度的影响:一项澳大利亚土著人视角的研究。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001135.
7
Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults.比较澳大利亚原住民和澳大利亚白种成年人的一氧化碳弥散量(DLCO)和肺总量(TLC)。
PLoS One. 2021 Apr 2;16(4):e0248900. doi: 10.1371/journal.pone.0248900. eCollection 2021.
8
Spirometry in Asthma Care: A Review of the Trends and Challenges in Pediatric Practice.哮喘护理中的肺功能测定:儿科实践中的趋势与挑战综述。
Clin Med Insights Pediatr. 2017 Jul 19;11:1179556517720675. doi: 10.1177/1179556517720675. eCollection 2017.